1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of ABHD5 mRNA CTD PMID:28960355 1,2-dimethylhydrazine affects expression EXP 6480464 1 and 2-Dimethylhydrazine affects the expression of ABHD5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD5 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of ABHD5 mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ABHD5 mRNA CTD PMID:15328365 and PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ABHD5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABHD5 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABHD5 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ABHD5 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO ABHD5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of ABHD5 mRNA CTD PMID:19684285 2-hydroxypropanoic acid decreases expression ISO ABHD5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ABHD5 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of ABHD5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO ABHD5 (Homo sapiens) 6480464 Decitabine affects the expression of ABHD5 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of ABHD5 mRNA CTD PMID:30047161 acetamide decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 acetamide results in decreased expression of ABHD5 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ABHD5 mRNA CTD PMID:30807115 acrylamide increases expression ISO ABHD5 (Homo sapiens) 6480464 Acrylamide results in increased expression of ABHD5 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ABHD5 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO ABHD5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of ABHD5 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO ABHD5 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of ABHD5 mRNA CTD PMID:22100608 amitrole decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Amitrole results in decreased expression of ABHD5 mRNA CTD PMID:30047161 aristolochic acid A increases expression ISO ABHD5 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of ABHD5 mRNA and aristolochic acid I results in increased expression of ABHD5 protein CTD PMID:33212167 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ABHD5 mRNA CTD PMID:23650126 arsenous acid multiple interactions ISO ABHD5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD5 protein] CTD PMID:26598702 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ABHD5 mRNA CTD PMID:22228805 benzo[a]pyrene increases expression ISO ABHD5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of ABHD5 mRNA CTD PMID:21632981 more ... benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ABHD5 mRNA CTD PMID:19770486 and PMID:21715664 benzo[a]pyrene diol epoxide I decreases expression ISO ABHD5 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 bisphenol A increases expression ISO Abhd5 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of ABHD5 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of ABHD5 mRNA CTD PMID:32145629 and PMID:35192832 bisphenol A increases methylation ISO ABHD5 (Homo sapiens) 6480464 bisphenol A results in increased methylation of ABHD5 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ABHD5 mRNA CTD PMID:34585602 bisphenol A multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO ABHD5 (Homo sapiens) 6480464 bisphenol B results in increased expression of ABHD5 protein CTD PMID:34186270 cadmium atom multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD5 mRNA CTD PMID:35301059 cadmium dichloride affects expression ISO Abhd5 (Rattus norvegicus) 6480464 Cadmium Chloride affects the expression of ABHD5 mRNA CTD PMID:22110744 cadmium dichloride multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD5 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions EXP 6480464 [MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in increased expression of ABHD5 mRNA and [MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in increased expression of ABHD5 mRNA CTD PMID:23921151 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 cisplatin increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Cisplatin results in increased expression of ABHD5 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ABHD5 mRNA CTD PMID:27392435 cisplatin affects expression ISO ABHD5 (Homo sapiens) 6480464 Cisplatin affects the expression of ABHD5 mRNA CTD PMID:23300844 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ABHD5 mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO Abhd5 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of ABHD5 mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO ABHD5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ABHD5 mRNA CTD PMID:19549813 Cuprizon decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of ABHD5 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO ABHD5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of ABHD5 mRNA CTD PMID:20106945 more ... dexamethasone increases expression ISO ABHD5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of ABHD5 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO ABHD5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ABHD5 protein] CTD PMID:26598702 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 dicrotophos decreases expression ISO ABHD5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of ABHD5 mRNA CTD PMID:28302478 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of ABHD5 mRNA CTD PMID:22629407 dioxygen multiple interactions EXP 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ABHD5 mRNA] CTD PMID:22629407 dorsomorphin multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO ABHD5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ABHD5 mRNA CTD PMID:29803840 ethanol affects expression EXP 6480464 Ethanol affects the expression of ABHD5 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO ABHD5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of ABHD5 mRNA CTD PMID:23649840 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of ABHD5 mRNA CTD PMID:25629700 folic acid multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD5 mRNA CTD PMID:22206623 formaldehyde increases expression ISO ABHD5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of ABHD5 mRNA CTD PMID:23649840 furan increases expression EXP 6480464 furan results in increased expression of ABHD5 mRNA CTD PMID:24183702 gentamycin increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ABHD5 mRNA CTD PMID:33387578 indometacin multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ABHD5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ABHD5 mRNA CTD PMID:28628672 isotretinoin decreases expression ISO ABHD5 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of ABHD5 mRNA CTD PMID:20436886 ketamine decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Ketamine results in decreased expression of ABHD5 mRNA CTD PMID:20080153 levonorgestrel multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA CTD PMID:19074003 menadione affects expression ISO ABHD5 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of ABHD5 mRNA CTD PMID:20044591 methapyrilene increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Methapyrilene results in increased expression of ABHD5 mRNA CTD PMID:30467583 methimazole decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Methimazole results in decreased expression of ABHD5 mRNA CTD PMID:30047161 methyl methanesulfonate increases expression ISO ABHD5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ABHD5 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO ABHD5 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ABHD5 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO ABHD5 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of ABHD5 mRNA CTD PMID:28001369 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ABHD5 mRNA CTD PMID:24535843 nickel atom decreases expression ISO ABHD5 (Homo sapiens) 6480464 Nickel results in decreased expression of ABHD5 mRNA CTD PMID:24768652 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ABHD5 mRNA CTD PMID:17562736 paracetamol increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of ABHD5 mRNA CTD PMID:33387578 paracetamol increases expression ISO ABHD5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ABHD5 mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ABHD5 mRNA CTD PMID:36331819 phenobarbital affects expression ISO ABHD5 (Homo sapiens) 6480464 Phenobarbital affects the expression of ABHD5 mRNA CTD PMID:19159669 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of ABHD5 mRNA CTD PMID:23091169 phenytoin increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Phenytoin results in increased expression of ABHD5 mRNA CTD PMID:20345932 pirinixic acid multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ABHD5 mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ABHD5 mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Pregnenolone Carbonitrile results in decreased expression of ABHD5 mRNA CTD PMID:30047161 progesterone increases expression ISO ABHD5 (Homo sapiens) 6480464 Progesterone results in increased expression of ABHD5 mRNA CTD PMID:20864642 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of ABHD5 mRNA CTD PMID:21278054 quercetin affects expression ISO ABHD5 (Homo sapiens) 6480464 Quercetin affects the expression of ABHD5 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO ABHD5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ABHD5 mRNA CTD PMID:30851411 raloxifene affects expression ISO ABHD5 (Homo sapiens) 6480464 Raloxifene Hydrochloride affects the expression of ABHD5 mRNA CTD PMID:14699072 SB 431542 multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Silicon Dioxide results in increased expression of ABHD5 mRNA CTD PMID:22431001 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of ABHD5 mRNA CTD PMID:30953684 sodium arsenite affects methylation ISO ABHD5 (Homo sapiens) 6480464 sodium arsenite affects the methylation of ABHD5 gene CTD PMID:28589171 sulfadimethoxine decreases expression ISO Abhd5 (Rattus norvegicus) 6480464 Sulfadimethoxine results in decreased expression of ABHD5 mRNA CTD PMID:30047161 testosterone undecanoate multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA CTD PMID:19074003 thioacetamide increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of ABHD5 mRNA CTD PMID:23411599 tremolite asbestos increases expression EXP 6480464 tremolite results in increased expression of ABHD5 mRNA CTD PMID:29279043 trichloroethene increases expression ISO Abhd5 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of ABHD5 mRNA CTD PMID:33387578 triphenyl phosphate increases expression ISO Abhd5 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of ABHD5 mRNA CTD PMID:30589522 Triptolide increases expression EXP 6480464 triptolide results in increased expression of ABHD5 mRNA CTD PMID:32835833 urethane increases expression ISO ABHD5 (Homo sapiens) 6480464 Urethane results in increased expression of ABHD5 mRNA CTD PMID:28818685 valproic acid affects expression ISO ABHD5 (Homo sapiens) 6480464 Valproic Acid affects the expression of ABHD5 mRNA CTD PMID:25979313 valproic acid decreases expression ISO ABHD5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of ABHD5 mRNA and Valproic Acid results in decreased expression of ABHD5 protein CTD PMID:25716160 and PMID:29501571 valproic acid multiple interactions ISO ABHD5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD5 mRNA CTD PMID:27188386 valproic acid increases expression ISO ABHD5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ABHD5 mRNA CTD PMID:23179753 and PMID:26272509 vinclozolin increases expression ISO Abhd5 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of ABHD5 mRNA CTD PMID:23034163 zinc sulfate decreases expression ISO ABHD5 (Homo sapiens) 6480464 Zinc Sulfate results in decreased expression of ABHD5 mRNA CTD PMID:16330358
